Free Trial

Neoleukin Therapeutics (NLTX) Insider Trading & Ownership

Neoleukin Therapeutics logo
$28.94 +0.72 (+2.55%)
As of 05/5/2026

Neoleukin Therapeutics (NASDAQ:NLTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.58%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$1.31M
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$818.40
Get NLTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neoleukin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NLTX Insider Buying and Selling by Quarter

Neoleukin Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2023
Bros. Advisors Lp Baker
Director
Buy8,347$13.80$115,188.60  
8/15/2023
Bros. Advisors Lp Baker
Director
Buy94,440$12.60$1,189,944.00  
8/11/2023
Sean Michael Smith
CFO
Sell66$12.40$818.40  
(Data available from 1/1/2013 forward)

NLTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Neoleukin Therapeutics includes Bros. Advisors Lp Baker, and Sean Michael Smith. Learn more on insiders at NLTX.

1.58% of Neoleukin Therapeutics stock is owned by insiders. Learn more on NLTX's insider holdings.

Neoleukin Therapeutics Active Insiders



This page (NASDAQ:NLTX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners